Skip to main content
. 2023 Jul 12;63(5):711–715. doi: 10.2169/internalmedicine.1286-22

Table 2.

Case Reports of Alectinib-related Anemia.

Reference number Age/
Gender
Disesases DAT Erythrocyte morphological change Decrease of Hpt
(3) 85/M NSCLC Negative (+) (+)
(4) 62/M NSCLC, α-thalassaemia Negative (+) (+)
(5) 66/M NSCLC, β-thalassaemia Negative (+) (+)
77/F NSCLC Negative (+) (-)
(6) 79/F NSCLC No mention (+) No mention
66/M NSCLC No mention (+) No mention
14/F NSCLC Negative (+) (-)
30/F Neuroblastoma No mention (+) (-)
66/M NSCLC, β-thalassaemia Negative (+) (+)
77/F NSCLC Negative (+) (+)

DAT: direct antiglublin test, Hpt: haptoglobin, NSCLC: non-small cell lung carcinoma